Vaccines at Work
Roberto Mosquera () and
No 116, TWI Research Paper Series from Thurgauer Wirtschaftsinstitut, UniversitÃ¤t Konstanz
Influenza imposes substantial costs worldwide in terms of human lives and productivity losses. Vaccination could be a cost-effective way to reduce these costs for firms and public health institutions, but low take-up rates, particularly of working adults, and vaccination unintendingly causing moral hazard may decrease its benefits. We ran a natural field experiment in cooperation with a major bank in Ecuador where we modified a company-wide vaccination campaign. Experimentally manipulating incentives to participate in this health intervention allows us to study peer effects with organizational data and to determine the personal consequences of being randomly encouraged to take part in the campaign. We find that assigning employees to get vaccinated during the workweek increased take-up by 112% compared to employees assigned to the weekend, which indicates that reducing opportunity costs plays an important role to increase vaccination rates. Peer take-up also increased individual take-up significantly. Contrary to the company's expectations, we find that the effect of vaccination on health outcomes is a precise zero with no measurable health externalities from coworkers. Using a dataset of administrative records on sickness diagnoses and employee surveys, we find evidence consistent with vaccination causing moral hazard, which could decrease the effectiveness of vaccination.
Keywords: Health Intervention; Flu Vaccination; Sickness-Related Absence; Field Experiment; Random Encouragement Design; Moral Hazard; Technology Adoption (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-exp, nep-hea and nep-hrm
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
https://www.twi-kreuzlingen.ch/wp-content/uploads/ ... n-Mosquera-Chadi.pdf
Working Paper: Vaccines at Work (2020)
Working Paper: Vaccines at Work (2019)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:twi:respas:0116
Access Statistics for this paper
More papers in TWI Research Paper Series from Thurgauer Wirtschaftsinstitut, UniversitÃ¤t Konstanz Contact information at EDIRC.
Bibliographic data for series maintained by Urs Fischbacher ().